文献速递脑血管病外科神经重症

和肽素作为精氨酸加压素替代标志物与动脉瘤性蛛网膜下腔出血后脑血管痉挛及迟发性缺血性神经功能缺损的相关性

Association of copeptin, a surrogate marker of arginine vasopressin, with cerebral vasospasm and delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage.
PubMed 文献 · J Neurosurg · 2018-05-04

该研究在19例患者(10例迟发性缺血性神经功能缺损、6例无缺损、3例对照)中检测脑脊液和肽素浓度,发现缺损组和无缺损组均高于对照组,低钠血症的缺损组高于低钠血症的无缺损组,缺损与血钠下降伴和肽素升高相关,作者认为加压素升高可能是低钠血症与缺损共存的原因,需进一步研究。

要点

  • 脑脊液和肽素在迟发性缺血性神经功能缺损组和无缺损组均高于对照组。
  • 低钠血症的缺损组和肽素高于低钠血症的无缺损组。
  • 缺损与血钠下降伴和肽素升高相关,作者认为加压素升高可能是共同原因。

核心结论

  • 作者认为加压素升高可能是解释低钠血症与迟发性缺血性神经功能缺损共存的因素。
  • 作者指出需进一步研究该关系及加压素拮抗剂在临床中的治疗价值。

研究设计与样本

  • 研究采用酶联免疫吸附法检测19例患者脑脊液和肽素浓度,其中迟发性缺血性神经功能缺损10例、无缺损6例、对照3例。

主要发现

  • 迟发性缺血性神经功能缺损组和无缺损组的和肽素浓度均高于对照组。
  • 低钠血症的迟发性缺血性神经功能缺损组和肽素浓度高于低钠血症的无缺损组。
  • 迟发性缺血性神经功能缺损与血钠水平下降伴和肽素浓度升高相关。

局限性

  • 作者指出需进一步研究该关系及加压素拮抗剂在临床中的治疗价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delayed ischemic neurological deficit (DIND) is a leading cause of mortality and morbidity after aneurysmal subarachnoid hemorrhage (aSAH). Arginine vasopressin (AVP) is a hormone released by the posterior pituitary. It is known to cause cerebral vasoconstriction and has been implicated in hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion. Direct measurement of AVP is limited by its short half-life. Copeptin, a cleavage product of the AVP precursor protein, was therefore used as a surrogate marker for AVP. This study aimed to investigate the temporal relationship between changes in copeptin concentrations and episodes of DIND and hyponatremia. METHODS: Copeptin concentrations in cerebrospinal fluid were quantified using enzyme-linked immunosorbent assay in 19 patients: 10 patients with DIND, 6 patients without DIND (no-DIND), and 3 controls. RESULTS: Copeptin concentrations were higher in DIND and no-DIND patients than in controls. In hyponatremic DIND patients, copeptin concentrations were higher compared with hyponatremic no-DIND patients. DIND was associated with a combination of decreasing sodium levels and increasing copeptin concentrations. CONCLUSIONS: Increased AVP may be the unifying factor explaining the co-occurrence of hyponatremia and DIND. Future studies are indicated to investigate this relationship and the therapeutic utility of AVP antagonists in the clinical setting.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Fernandez SJ, Barakat I, Ziogas J, et al. Association of copeptin, a surrogate marker of arginine vasopressin, with cerebral vasospasm and delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2018. PMID: 29726784. doi:10.3171/2017.10.JNS17795

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。